OMEZ 40 + OMEZ 80

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

GERD

Conditions

GERD

Trial Timeline

Jan 1, 2013 โ†’ Jun 1, 2013

About OMEZ 40 + OMEZ 80

OMEZ 40 + OMEZ 80 is a approved stage product being developed by Dr. Reddy's Laboratories for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT02922699. Target conditions include GERD.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02922699ApprovedCompleted

Competing Products

20 competing products in GERD

See all competitors
ProductCompanyStageHype Score
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodiumEisaiPhase 1
33
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
rabeprazole sodium + PlaceboEisaiPhase 3
77
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mgEisaiPhase 1
33
rabeprazole + rabeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
ONO-8539Ono PharmaceuticalPhase 1
33
esomeprazole 40 mgJohnson & JohnsonPre-clinical
23
esomeprazole (Nexiumยฎ) + XolaamยฎAstraZenecaApproved
85
esomeprazoleAstraZenecaPre-clinical
23
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaApproved
85
esomeprazole magnesiumAstraZenecaPhase 1
33
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaPhase 3
77
Esomeprazole (Nexium)AstraZenecaApproved
85
OmeprazoleAstraZenecaPhase 3
77